CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −1,138 | 10,248 | ||
| 2023-03-02 | Hoge Stephen President | Sale | −1,177 | $136.43 | $161K | 1,630,460 |
| 2023-03-02 | Klinger Shannon Thyme Chief Legal Officer | Sale | −459 | $136.43 | $63K | 5,243 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Sale | −8,700 | $136.44 | $1.2M | 5,443,246 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Sale | −17,541 | $137.42 | $2.4M | 5,425,705 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Sale | −13,659 | $138.27 | $1.9M | 5,412,046 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Sale | −100 | $139.03 | $14K | 5,411,946 |
| 2023-03-02 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,307,155 | ||
| 2023-03-01 | Hoge Stephen President | Exercise or conversion | +2,606 | 1,631,637 | ||
| 2023-03-01 | Hoge Stephen President | Exercise or conversion · Restricted Stock Units | −2,606 | 7,819 | ||
| 2023-03-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion | +930 | 5,702 | ||
| 2023-03-01 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units | −930 | 2,791 | ||
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Sale | −11,319 | $134.34 | $1.5M | 5,440,627 |
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Sale | −21,938 | $135.26 | $3.0M | 5,418,689 |
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Sale | −5,593 | $136.17 | $762K | 5,413,096 |
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Sale | −1,150 | $137.03 | $158K | 5,411,946 |
| 2023-03-01 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 1,347,155 | ||
| 2023-03-01 | AFEYAN NOUBAR Director | Sale | −10,000 | $139.00 | $1.4M | 2,187,209 |
Page 54 of 66 · 1,314 trades